Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells

Hepatocellular carcinoma is the fifth most common type of cancer worldwide and remains difficult to treat. The aim of this study was to investigate the effects of mesenchymal stem cells (MSCs) derived from the umbilical cord (UC-MSCs) on HepG2 hepatocellular carcinoma cells. UC-MSCs were co-cultured...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular medicine reports 2016-09, Vol.14 (3), p.2717-2724
Hauptverfasser: Tang, Ying-Mei, Bao, Wei-Min, Yang, Jin-Hui, Ma, Lin-Kun, Yang, Jing, Xu, Ying, Yang, Li-Hong, Sha, Feng, Xu, Zhi-Yuan, Wu, Hua-Mei, Zhou, Wei, Li, Yan, Li, Yu-Hua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2724
container_issue 3
container_start_page 2717
container_title Molecular medicine reports
container_volume 14
creator Tang, Ying-Mei
Bao, Wei-Min
Yang, Jin-Hui
Ma, Lin-Kun
Yang, Jing
Xu, Ying
Yang, Li-Hong
Sha, Feng
Xu, Zhi-Yuan
Wu, Hua-Mei
Zhou, Wei
Li, Yan
Li, Yu-Hua
description Hepatocellular carcinoma is the fifth most common type of cancer worldwide and remains difficult to treat. The aim of this study was to investigate the effects of mesenchymal stem cells (MSCs) derived from the umbilical cord (UC-MSCs) on HepG2 hepatocellular carcinoma cells. UC-MSCs were co-cultured with HepG2 cells and biomarkers of UC-MSCs were analyzed by flow cytometry. mRNA and protein expression of genes were determined by reverse transcription-polymerase chain reaction and flow cytometry, respectively. Passage three and seven UC-MSCs expressed CD29, CD44, CD90 and CD105, whereas CD34 and CD45 were absent on these cells. Co-culture with UC-MSCs inhibited proliferation and promoted apoptosis of HepG2 cells in a time-dependent manner. The initial seeding density of UC-MSCs also influenced the proliferation and apoptosis of HepG2 cells, with an increased number of UC-MSCs causing enhanced proliferation inhibition and cell apoptosis. Co-culture with UC-MSCs downregulated mRNA and protein expression of α-fetoprotein (AFP), Bcl-2 and Survivin in HepG2 cells. Thus, UC-MSCs may inhibit growth and promote apoptosis of HepG2 cells through downregulation of AFP, Bcl-2 and Survivin. US-MSCs may be used as a novel therapy for treating hepatocellular carcinoma in the future.
doi_str_mv 10.3892/mmr.2016.5537
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1810354782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A462982524</galeid><sourcerecordid>A462982524</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-6629cd981ffd034dc1593cb9a6dc9e080c5707474f8dd4ffb285a273c531ccd3</originalsourceid><addsrcrecordid>eNptkc1rHCEchofS0qRpj70WoYfk4tbPUY8hNEkhkEt6FsePrGEcpzrbkP--DrtJaQkKij6_lxeervuM0YZKRb6lVDYE4X7DORVvumMsFIYUIfb2cCdKiaPuQ60PCPWccPW-OyKCSd72cWd-piGO0ZoR2FwcdL7E396B5Kuf7PYptY-6-ASsH8cK4rSNQ1zAfcmPyxaYyYG55JQXD8yc5yXXWEEO4NrPV2Q_87F7F8xY_afDedLdXX6_u7iGN7dXPy7Ob6BlXC2w74myTkkcgkOUOYu5onZQpndWeSSR5QIJJliQzrEQBiK5IYJaTrG1jp50Z_vY1ufXztdFp1jXAmbyeVc1lhhRzoQkDf36H_qQd2Vq5TRWlDQGEfmXujej13EKeSnGrqH6nLWyknDCGrV5hWrL-RRtnnyI7f2fAbgfsCXXWnzQc4nJlCeNkV6N6mZUr0b1arTxXw5ld0Py7oV-VtiA0z1Q56YjulxfmJYEMYOIQiKwoH8A31en3w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1932478028</pqid></control><display><type>article</type><title>Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Tang, Ying-Mei ; Bao, Wei-Min ; Yang, Jin-Hui ; Ma, Lin-Kun ; Yang, Jing ; Xu, Ying ; Yang, Li-Hong ; Sha, Feng ; Xu, Zhi-Yuan ; Wu, Hua-Mei ; Zhou, Wei ; Li, Yan ; Li, Yu-Hua</creator><creatorcontrib>Tang, Ying-Mei ; Bao, Wei-Min ; Yang, Jin-Hui ; Ma, Lin-Kun ; Yang, Jing ; Xu, Ying ; Yang, Li-Hong ; Sha, Feng ; Xu, Zhi-Yuan ; Wu, Hua-Mei ; Zhou, Wei ; Li, Yan ; Li, Yu-Hua</creatorcontrib><description>Hepatocellular carcinoma is the fifth most common type of cancer worldwide and remains difficult to treat. The aim of this study was to investigate the effects of mesenchymal stem cells (MSCs) derived from the umbilical cord (UC-MSCs) on HepG2 hepatocellular carcinoma cells. UC-MSCs were co-cultured with HepG2 cells and biomarkers of UC-MSCs were analyzed by flow cytometry. mRNA and protein expression of genes were determined by reverse transcription-polymerase chain reaction and flow cytometry, respectively. Passage three and seven UC-MSCs expressed CD29, CD44, CD90 and CD105, whereas CD34 and CD45 were absent on these cells. Co-culture with UC-MSCs inhibited proliferation and promoted apoptosis of HepG2 cells in a time-dependent manner. The initial seeding density of UC-MSCs also influenced the proliferation and apoptosis of HepG2 cells, with an increased number of UC-MSCs causing enhanced proliferation inhibition and cell apoptosis. Co-culture with UC-MSCs downregulated mRNA and protein expression of α-fetoprotein (AFP), Bcl-2 and Survivin in HepG2 cells. Thus, UC-MSCs may inhibit growth and promote apoptosis of HepG2 cells through downregulation of AFP, Bcl-2 and Survivin. US-MSCs may be used as a novel therapy for treating hepatocellular carcinoma in the future.</description><identifier>ISSN: 1791-2997</identifier><identifier>EISSN: 1791-3004</identifier><identifier>DOI: 10.3892/mmr.2016.5537</identifier><identifier>PMID: 27485485</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>Antigens, Surface - metabolism ; Apoptosis ; Bcl-2 protein ; Biomarkers ; Biomarkers, Tumor ; Breast cancer ; Care and treatment ; CD105 antigen ; CD29 antigen ; CD34 antigen ; CD44 antigen ; CD45 antigen ; CD90 antigen ; Cell culture ; Cell Differentiation ; Cell growth ; Cell Proliferation ; co-culture ; Coculture Techniques ; Cytokines ; Flow cytometry ; Gene expression ; Gene Expression Regulation, Neoplastic ; Growth factors ; Health aspects ; Hep G2 Cells ; Hepatocellular carcinoma ; Hepatoma ; HepG2 cells ; Humans ; Immunoglobulins ; Immunophenotyping ; Liver cancer ; Mesenchymal stem cells ; Mesenchymal Stromal Cells - cytology ; Mesenchymal Stromal Cells - metabolism ; Mesenchyme ; Metastasis ; Polymerase chain reaction ; proliferation ; Reverse transcription ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Stem cells ; Studies ; Survivin ; Umbilical cord ; Umbilical Cord - cytology ; umbilical cord-derived mesenchymal stem cells</subject><ispartof>Molecular medicine reports, 2016-09, Vol.14 (3), p.2717-2724</ispartof><rights>Copyright © 2016, Spandidos Publications</rights><rights>COPYRIGHT 2016 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-6629cd981ffd034dc1593cb9a6dc9e080c5707474f8dd4ffb285a273c531ccd3</citedby><cites>FETCH-LOGICAL-c459t-6629cd981ffd034dc1593cb9a6dc9e080c5707474f8dd4ffb285a273c531ccd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,5556,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27485485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Ying-Mei</creatorcontrib><creatorcontrib>Bao, Wei-Min</creatorcontrib><creatorcontrib>Yang, Jin-Hui</creatorcontrib><creatorcontrib>Ma, Lin-Kun</creatorcontrib><creatorcontrib>Yang, Jing</creatorcontrib><creatorcontrib>Xu, Ying</creatorcontrib><creatorcontrib>Yang, Li-Hong</creatorcontrib><creatorcontrib>Sha, Feng</creatorcontrib><creatorcontrib>Xu, Zhi-Yuan</creatorcontrib><creatorcontrib>Wu, Hua-Mei</creatorcontrib><creatorcontrib>Zhou, Wei</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Li, Yu-Hua</creatorcontrib><title>Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells</title><title>Molecular medicine reports</title><addtitle>Mol Med Rep</addtitle><description>Hepatocellular carcinoma is the fifth most common type of cancer worldwide and remains difficult to treat. The aim of this study was to investigate the effects of mesenchymal stem cells (MSCs) derived from the umbilical cord (UC-MSCs) on HepG2 hepatocellular carcinoma cells. UC-MSCs were co-cultured with HepG2 cells and biomarkers of UC-MSCs were analyzed by flow cytometry. mRNA and protein expression of genes were determined by reverse transcription-polymerase chain reaction and flow cytometry, respectively. Passage three and seven UC-MSCs expressed CD29, CD44, CD90 and CD105, whereas CD34 and CD45 were absent on these cells. Co-culture with UC-MSCs inhibited proliferation and promoted apoptosis of HepG2 cells in a time-dependent manner. The initial seeding density of UC-MSCs also influenced the proliferation and apoptosis of HepG2 cells, with an increased number of UC-MSCs causing enhanced proliferation inhibition and cell apoptosis. Co-culture with UC-MSCs downregulated mRNA and protein expression of α-fetoprotein (AFP), Bcl-2 and Survivin in HepG2 cells. Thus, UC-MSCs may inhibit growth and promote apoptosis of HepG2 cells through downregulation of AFP, Bcl-2 and Survivin. US-MSCs may be used as a novel therapy for treating hepatocellular carcinoma in the future.</description><subject>Antigens, Surface - metabolism</subject><subject>Apoptosis</subject><subject>Bcl-2 protein</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor</subject><subject>Breast cancer</subject><subject>Care and treatment</subject><subject>CD105 antigen</subject><subject>CD29 antigen</subject><subject>CD34 antigen</subject><subject>CD44 antigen</subject><subject>CD45 antigen</subject><subject>CD90 antigen</subject><subject>Cell culture</subject><subject>Cell Differentiation</subject><subject>Cell growth</subject><subject>Cell Proliferation</subject><subject>co-culture</subject><subject>Coculture Techniques</subject><subject>Cytokines</subject><subject>Flow cytometry</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Growth factors</subject><subject>Health aspects</subject><subject>Hep G2 Cells</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatoma</subject><subject>HepG2 cells</subject><subject>Humans</subject><subject>Immunoglobulins</subject><subject>Immunophenotyping</subject><subject>Liver cancer</subject><subject>Mesenchymal stem cells</subject><subject>Mesenchymal Stromal Cells - cytology</subject><subject>Mesenchymal Stromal Cells - metabolism</subject><subject>Mesenchyme</subject><subject>Metastasis</subject><subject>Polymerase chain reaction</subject><subject>proliferation</subject><subject>Reverse transcription</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Stem cells</subject><subject>Studies</subject><subject>Survivin</subject><subject>Umbilical cord</subject><subject>Umbilical Cord - cytology</subject><subject>umbilical cord-derived mesenchymal stem cells</subject><issn>1791-2997</issn><issn>1791-3004</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkc1rHCEchofS0qRpj70WoYfk4tbPUY8hNEkhkEt6FsePrGEcpzrbkP--DrtJaQkKij6_lxeervuM0YZKRb6lVDYE4X7DORVvumMsFIYUIfb2cCdKiaPuQ60PCPWccPW-OyKCSd72cWd-piGO0ZoR2FwcdL7E396B5Kuf7PYptY-6-ASsH8cK4rSNQ1zAfcmPyxaYyYG55JQXD8yc5yXXWEEO4NrPV2Q_87F7F8xY_afDedLdXX6_u7iGN7dXPy7Ob6BlXC2w74myTkkcgkOUOYu5onZQpndWeSSR5QIJJliQzrEQBiK5IYJaTrG1jp50Z_vY1ufXztdFp1jXAmbyeVc1lhhRzoQkDf36H_qQd2Vq5TRWlDQGEfmXujej13EKeSnGrqH6nLWyknDCGrV5hWrL-RRtnnyI7f2fAbgfsCXXWnzQc4nJlCeNkV6N6mZUr0b1arTxXw5ld0Py7oV-VtiA0z1Q56YjulxfmJYEMYOIQiKwoH8A31en3w</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Tang, Ying-Mei</creator><creator>Bao, Wei-Min</creator><creator>Yang, Jin-Hui</creator><creator>Ma, Lin-Kun</creator><creator>Yang, Jing</creator><creator>Xu, Ying</creator><creator>Yang, Li-Hong</creator><creator>Sha, Feng</creator><creator>Xu, Zhi-Yuan</creator><creator>Wu, Hua-Mei</creator><creator>Zhou, Wei</creator><creator>Li, Yan</creator><creator>Li, Yu-Hua</creator><general>D.A. Spandidos</general><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells</title><author>Tang, Ying-Mei ; Bao, Wei-Min ; Yang, Jin-Hui ; Ma, Lin-Kun ; Yang, Jing ; Xu, Ying ; Yang, Li-Hong ; Sha, Feng ; Xu, Zhi-Yuan ; Wu, Hua-Mei ; Zhou, Wei ; Li, Yan ; Li, Yu-Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-6629cd981ffd034dc1593cb9a6dc9e080c5707474f8dd4ffb285a273c531ccd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antigens, Surface - metabolism</topic><topic>Apoptosis</topic><topic>Bcl-2 protein</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor</topic><topic>Breast cancer</topic><topic>Care and treatment</topic><topic>CD105 antigen</topic><topic>CD29 antigen</topic><topic>CD34 antigen</topic><topic>CD44 antigen</topic><topic>CD45 antigen</topic><topic>CD90 antigen</topic><topic>Cell culture</topic><topic>Cell Differentiation</topic><topic>Cell growth</topic><topic>Cell Proliferation</topic><topic>co-culture</topic><topic>Coculture Techniques</topic><topic>Cytokines</topic><topic>Flow cytometry</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Growth factors</topic><topic>Health aspects</topic><topic>Hep G2 Cells</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatoma</topic><topic>HepG2 cells</topic><topic>Humans</topic><topic>Immunoglobulins</topic><topic>Immunophenotyping</topic><topic>Liver cancer</topic><topic>Mesenchymal stem cells</topic><topic>Mesenchymal Stromal Cells - cytology</topic><topic>Mesenchymal Stromal Cells - metabolism</topic><topic>Mesenchyme</topic><topic>Metastasis</topic><topic>Polymerase chain reaction</topic><topic>proliferation</topic><topic>Reverse transcription</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Stem cells</topic><topic>Studies</topic><topic>Survivin</topic><topic>Umbilical cord</topic><topic>Umbilical Cord - cytology</topic><topic>umbilical cord-derived mesenchymal stem cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Ying-Mei</creatorcontrib><creatorcontrib>Bao, Wei-Min</creatorcontrib><creatorcontrib>Yang, Jin-Hui</creatorcontrib><creatorcontrib>Ma, Lin-Kun</creatorcontrib><creatorcontrib>Yang, Jing</creatorcontrib><creatorcontrib>Xu, Ying</creatorcontrib><creatorcontrib>Yang, Li-Hong</creatorcontrib><creatorcontrib>Sha, Feng</creatorcontrib><creatorcontrib>Xu, Zhi-Yuan</creatorcontrib><creatorcontrib>Wu, Hua-Mei</creatorcontrib><creatorcontrib>Zhou, Wei</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Li, Yu-Hua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular medicine reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Ying-Mei</au><au>Bao, Wei-Min</au><au>Yang, Jin-Hui</au><au>Ma, Lin-Kun</au><au>Yang, Jing</au><au>Xu, Ying</au><au>Yang, Li-Hong</au><au>Sha, Feng</au><au>Xu, Zhi-Yuan</au><au>Wu, Hua-Mei</au><au>Zhou, Wei</au><au>Li, Yan</au><au>Li, Yu-Hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells</atitle><jtitle>Molecular medicine reports</jtitle><addtitle>Mol Med Rep</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>14</volume><issue>3</issue><spage>2717</spage><epage>2724</epage><pages>2717-2724</pages><issn>1791-2997</issn><eissn>1791-3004</eissn><abstract>Hepatocellular carcinoma is the fifth most common type of cancer worldwide and remains difficult to treat. The aim of this study was to investigate the effects of mesenchymal stem cells (MSCs) derived from the umbilical cord (UC-MSCs) on HepG2 hepatocellular carcinoma cells. UC-MSCs were co-cultured with HepG2 cells and biomarkers of UC-MSCs were analyzed by flow cytometry. mRNA and protein expression of genes were determined by reverse transcription-polymerase chain reaction and flow cytometry, respectively. Passage three and seven UC-MSCs expressed CD29, CD44, CD90 and CD105, whereas CD34 and CD45 were absent on these cells. Co-culture with UC-MSCs inhibited proliferation and promoted apoptosis of HepG2 cells in a time-dependent manner. The initial seeding density of UC-MSCs also influenced the proliferation and apoptosis of HepG2 cells, with an increased number of UC-MSCs causing enhanced proliferation inhibition and cell apoptosis. Co-culture with UC-MSCs downregulated mRNA and protein expression of α-fetoprotein (AFP), Bcl-2 and Survivin in HepG2 cells. Thus, UC-MSCs may inhibit growth and promote apoptosis of HepG2 cells through downregulation of AFP, Bcl-2 and Survivin. US-MSCs may be used as a novel therapy for treating hepatocellular carcinoma in the future.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>27485485</pmid><doi>10.3892/mmr.2016.5537</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1791-2997
ispartof Molecular medicine reports, 2016-09, Vol.14 (3), p.2717-2724
issn 1791-2997
1791-3004
language eng
recordid cdi_proquest_miscellaneous_1810354782
source Spandidos Publications Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Antigens, Surface - metabolism
Apoptosis
Bcl-2 protein
Biomarkers
Biomarkers, Tumor
Breast cancer
Care and treatment
CD105 antigen
CD29 antigen
CD34 antigen
CD44 antigen
CD45 antigen
CD90 antigen
Cell culture
Cell Differentiation
Cell growth
Cell Proliferation
co-culture
Coculture Techniques
Cytokines
Flow cytometry
Gene expression
Gene Expression Regulation, Neoplastic
Growth factors
Health aspects
Hep G2 Cells
Hepatocellular carcinoma
Hepatoma
HepG2 cells
Humans
Immunoglobulins
Immunophenotyping
Liver cancer
Mesenchymal stem cells
Mesenchymal Stromal Cells - cytology
Mesenchymal Stromal Cells - metabolism
Mesenchyme
Metastasis
Polymerase chain reaction
proliferation
Reverse transcription
RNA, Messenger - genetics
RNA, Messenger - metabolism
Stem cells
Studies
Survivin
Umbilical cord
Umbilical Cord - cytology
umbilical cord-derived mesenchymal stem cells
title Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T13%3A26%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Umbilical%20cord-derived%20mesenchymal%20stem%20cells%20inhibit%20growth%20and%20promote%20apoptosis%20of%20HepG2%20cells&rft.jtitle=Molecular%20medicine%20reports&rft.au=Tang,%20Ying-Mei&rft.date=2016-09-01&rft.volume=14&rft.issue=3&rft.spage=2717&rft.epage=2724&rft.pages=2717-2724&rft.issn=1791-2997&rft.eissn=1791-3004&rft_id=info:doi/10.3892/mmr.2016.5537&rft_dat=%3Cgale_proqu%3EA462982524%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1932478028&rft_id=info:pmid/27485485&rft_galeid=A462982524&rfr_iscdi=true